QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 151 filers reported holding QIAGEN NV in Q3 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $319,000 | +0.3% | 11,400 | -1.7% | 0.00% | – |
| Q3 2016 | $318,000 | -77.7% | 11,600 | -82.3% | 0.00% | -100.0% |
| Q2 2016 | $1,426,000 | -32.7% | 65,400 | -31.1% | 0.00% | -50.0% |
| Q1 2016 | $2,120,000 | +147.4% | 94,900 | +206.1% | 0.00% | +100.0% |
| Q4 2015 | $857,000 | +19.0% | 31,000 | +1.0% | 0.00% | 0.0% |
| Q4 2014 | $720,000 | -6.5% | 30,700 | -14.7% | 0.00% | 0.0% |
| Q3 2013 | $770,000 | -81.7% | 36,000 | -83.0% | 0.00% | -75.0% |
| Q2 2013 | $4,211,000 | – | 211,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Exane Asset Management | 642,752 | $14,260,214,000 | 5.53% |
| Tikvah Management LLC | 369,425 | $8,057,000 | 4.72% |
| Hardman Johnston Global Advisors LLC | 3,797,024 | $82,813,000 | 4.22% |
| HealthCor Management, L.P. | 2,500,000 | $54,525,000 | 2.97% |
| Opus Point Partners Management, LLC | 105,751 | $2,306,000 | 2.23% |
| CRAMER ROSENTHAL MCGLYNN LLC | 4,018,074 | $87,634,000 | 1.41% |
| Douglas Lane & Associates, LLC | 1,942,678 | $42,370,000 | 1.22% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,167,768 | $47,279,000 | 1.17% |
| MANNING & NAPIER ADVISORS LLC | 6,111,364 | $133,287,000 | 0.81% |
| PRIMECAP MANAGEMENT CO/CA/ | 20,128,325 | $438,999,000 | 0.47% |